This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nees, M. Articles by Woodworth, C. D. Search for Related Content PubMed PubMed Citation Articles by Nees, M. Articles by Woodworth, C. D.

Human Papillomavirus Type 16 E6 and E7 Proteins Inhibit Differentiation-dependent Expression of Transforming Growth Factor-ß2 in Cervical Keratinocytes

Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute [M. N., J. M. G., C. D. W.], Center for Information Technology [P. M., V. P.], NIH, Bethesda, Maryland, 20892, and Department of Dermatology, New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111 [Y. L., E. A.]

Infection with high-risk human papillomaviruses (HPVs) represents a major risk factor for the development of cervical cancer. The HPV-16 E6 and E7 proteins are highly expressed in differentiating keratinocytes, where they inactivate the p53 and retinoblastoma (pRb) proteins, two important transcriptional regulators. We have used cDNA expression arrays to identify global alterations in gene expression induced by E6 and E7 in differentiating cultures of human cervical keratinocytes. We show that E6 and E7 decrease expression of TGF-ß2 mRNA and alter expression of multiple TGF-ß-responsive genes involved in cell cycle regulation, apoptosis, and tissue remodeling. E6 and E7 inhibited expression of TGF-ß2 RNA 7-fold (relative effectiveness, E6/E7 > E6 > E7 > control) and decreased secretion of biologically active TGF-ß2 by 70–80% (reduced from 70 to 10 pg/10⁶cells/24 h). Down-regulation occurred through p53- and pRb-dependent pathways. In contrast, E6 and E7 did not alter expression of TGF-ß1 and TGF-ß3. Down-regulation of TGF-ß2 was biologically relevant because the addition of recombinant cytokine (10–200 pg/ml) to E6/E7-expressing cells restored expression of TGF-ß-responsive genes, inhibited growth of keratinocytes, and decreased immortalization by E6 and E7. These results suggest that TGF-ß2- and TGF-ß-responsive genes are important targets for the HPV-16 E6 and E7 oncoproteins in differentiating cervical keratinocytes.

This article has been cited by other articles:

				A A Borbely, M Murvai, K Szarka, J Konya, L Gergely, Z Hernadi, and G Veress Survivin promoter polymorphism and cervical carcinogenesis J. Clin. Pathol., March 1, 2007; 60(3): 303 - 306. [Abstract] [Full Text] [PDF]

				M. A. de Boer, E. S. Jordanova, G. G. Kenter, A. A. Peters, W. E. Corver, J. B. Trimbos, and G. J. Fleuren High Human Papillomavirus Oncogene mRNA Expression and Not Viral DNA Load Is Associated with Poor Prognosis in Cervical Cancer Patients Clin. Cancer Res., January 1, 2007; 13(1): 132 - 138. [Abstract] [Full Text] [PDF]

				M. R. Pett, M. T. Herdman, R. D. Palmer, G. S. H. Yeo, M. K. Shivji, M. A. Stanley, and N. Coleman Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response PNAS, March 7, 2006; 103(10): 3822 - 3827. [Abstract] [Full Text] [PDF]

				A. A. Borbely, M. Murvai, J. Konya, Z. Beck, L. Gergely, F. Li, and G. Veress Effects of human papillomavirus type 16 oncoproteins on survivin gene expression J. Gen. Virol., February 1, 2006; 87(2): 287 - 294. [Abstract] [Full Text] [PDF]

				A. Baez, A. Cantor, S. Fonseca, M. Marcos-Martinez, L. A. Mathews, C. A. Muro-Cacho, and T. Munoz-Antonia Differences in Smad4 Expression in Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., May 1, 2005; 11(9): 3191 - 3197. [Abstract] [Full Text] [PDF]

				H. You, Y. Liu, M. J. Carey, C. L. Lowery, and P. L. Hermonat Defective 3A Trophoblast-Endometrial Cell Adhesion and Altered 3A Growth and Survival by Human Papillomavirus Type 16 Oncogenes Mol. Cancer Res., November 1, 2002; 1(1): 25 - 31. [Abstract] [Full Text] [PDF]

				A. J. Berger, A. Baege, T. Guillemette, J. Deeds, R. Meyer, G. Disbrow, R. Schlegel, and R. Schlegel Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins Am. J. Pathol., August 1, 2002; 161(2): 603 - 610. [Abstract] [Full Text] [PDF]

				M. Nees, J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-{kappa}B-Responsive Genes in Cervical Keratinocytes J. Virol., May 1, 2001; 75(9): 4283 - 4296. [Abstract] [Full Text]